Nabriva Therapeutics PLC - ADR (NBRV) Stock Has Gained 5.33% This Week: Buy, Hold, or Sell?

Friday, April 21, 2023 11:22 AM | InvestorsObserver Analysts

Mentioned in this article

Nabriva Therapeutics PLC - ADR (NBRV) Stock Has Gained 5.33% This Week: Buy, Hold, or Sell?

Nabriva Therapeutics PLC - ADR (NBRV) stock is down -82.35% over the last 12 months, and the average rating from Wall Street analysts is a Strong Sell. InvestorsObserver’s proprietary ranking system, gives NBRV stock a score of 22 out of a possible 100.

That rank is mainly influenced by a short-term technical score of 10. NBRV's rank also includes a long-term technical score of 19.

NBRV has an Overall Score of 22. Find out what this means to you and get the rest of the rankings on NBRV!

See Full NBRV Report

What's Happening with NBRV Stock Today

Nabriva Therapeutics PLC - ADR (NBRV) stock is down -1.25% while the S&P 500 is down -0.11% as of 10:52 AM on Friday, Apr 21. NBRV is down -$0.02 from the previous closing price of $1.60 on volume of 3,047 shares. Over the past year the S&P 500 is down -6.11% while NBRV is down -82.35%. NBRV lost -$21.32 per share in the over the last 12 months. Click Here to get the full Stock Report for Nabriva Therapeutics PLC - ADR stock.